Q3 2023 · 13F-HR
Affinity Asset Advisors, LLCholdings as filed
Filed 2023-11-14 · accession 0001999371-23-000200
$355.5M
Reported value
81
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $22.3M | 6.26% | 1,045,110 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $20.4M | 5.74% | 2,000,000 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $16.8M | 4.74% | 1,129,376 | Common | SOLE |
| 10806XAB8 | BBIO 2.5 03/15/27 | BRIDGEBIO PHARMA INC | $16.4M | 4.62% | 17,000,000 | Common | SOLE |
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $15.0M | 4.21% | 685,061 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $14.4M | 4.04% | 400,000 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $13.4M | 3.76% | 450,000 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $12.4M | 3.49% | 85,000 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $11.7M | 3.30% | 239,108 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $11.5M | 3.24% | 300,000 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $11.2M | 3.16% | 1,100,000 | CALL | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $10.3M | 2.89% | 300,438 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $7.8M | 2.20% | 856,535 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $7.5M | 2.10% | 1,000,300 | Common | SOLE |
| 00214Q302 | ARKG | ARK ETF TR | $7.0M | 1.96% | 250,000 | PUT | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $6.9M | 1.93% | 140,000 | CALL | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $6.8M | 1.91% | 230,366 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $6.7M | 1.88% | 57,500 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $6.6M | 1.85% | 1,018,091 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDG INC | $6.2M | 1.74% | 270,000 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $6.0M | 1.69% | 368,329 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $5.8M | 1.63% | 1,379,852 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $5.6M | 1.58% | 200,000 | CALL | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $4.9M | 1.39% | 130,000 | PUT | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $4.9M | 1.38% | 128,100 | PUT | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $4.6M | 1.31% | 1,992,466 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $4.3M | 1.22% | 1,150,000 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $4.3M | 1.22% | 46,400 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $4.1M | 1.16% | 150,000 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $4.1M | 1.14% | 60,000 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $3.9M | 1.11% | 350,000 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $3.8M | 1.08% | 79,214 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $3.7M | 1.04% | 332,600 | PUT | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $3.6M | 1.02% | 2,850,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $3.3M | 0.93% | 300,000 | Common | SOLE |
| 00773J202 | SYRE | AEGLEA BIOTHERAPEUTICS INC | $3.0M | 0.83% | 242,297 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $3.0M | 0.83% | 200,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $2.9M | 0.80% | 50,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $2.8M | 0.79% | 100,000 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $2.7M | 0.75% | 278,292 | Common | SOLE |
| 60468T105 | MRTXEUR | MIRATI THERAPEUTICS INC | $2.6M | 0.74% | 60,426 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $2.3M | 0.65% | 200,000 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $2.3M | 0.65% | 50,000 | Common | SOLE |
| 81181C104 | — | SEAGEN INC | $2.1M | 0.60% | 10,000 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $2.1M | 0.59% | 30,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $2.0M | 0.55% | 250,000 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $1.8M | 0.50% | 260,000 | PUT | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $1.8M | 0.49% | 150,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $1.6M | 0.46% | 325,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $1.5M | 0.43% | 40,000 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $1.3M | 0.36% | 25,000 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $1.2M | 0.35% | 6,293 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $1.2M | 0.35% | 155,000 | PUT | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $1.2M | 0.33% | 125,000 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDG INC | $1.1M | 0.32% | 50,000 | PUT | SOLE |
| 87410C104 | — | TALARIS THERAPEUTICS INC | $1.1M | 0.32% | 400,000 | Common | SOLE |
| 88369M101 | — | THESEUS PHARMACEUTICALS INC | $1.1M | 0.30% | 400,726 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $1.0M | 0.29% | 335,068 | Common | SOLE |
| 53000N108 | LIANY | LIANBIO | $1.0M | 0.28% | 672,357 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $986,700 | 0.28% | 1,100,000 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $968,789 | 0.27% | 325,097 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $961,353 | 0.27% | 41,581 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $948,000 | 0.27% | 30,000 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $894,000 | 0.25% | 100,000 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $797,450 | 0.22% | 5,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $791,100 | 0.22% | 30,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $784,358 | 0.22% | 30,156 | Common | SOLE |
| 05455M100 | — | AVROBIO INC | $770,000 | 0.22% | 500,000 | Common | SOLE |
| N44445117 | IMTXW | IMMATICS N.V | $662,702 | 0.19% | 187,204 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $575,912 | 0.16% | 37,300 | CALL | SOLE |
| 74587V107 | PBYI | PUMA BIOTECHNOLOGY INC | $532,178 | 0.15% | 202,349 | Common | SOLE |
| 74346M406 | PMNEUR | PROMIS NEUROSCIENCES INC | $526,677 | 0.15% | 265,958 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $496,514 | 0.14% | 328,817 | Common | SOLE |
| 590717104 | — | MESOBLAST LTD | $492,000 | 0.14% | 400,000 | PUT | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $335,000 | 0.09% | 250,000 | Common | SOLE |
| 09077B104 | BCABGBP | BIOATLA INC | $306,000 | 0.09% | 180,000 | Common | SOLE |
| 01438T106 | ALDX | ALDEYRA THERAPEUTICS INC | $296,245 | 0.08% | 44,348 | Common | SOLE |
| N62509117 | NAMSW | NEWAMSTERDAM PHARMA COMPANY | $260,300 | 0.07% | 137,000 | Common | SOLE |
| H57830103 | — | NLS PHARMACEUTICS LTD | $140,319 | 0.04% | 200,455 | Common | SOLE |
| 03890D108 | VSAREUR | ARAVIVE INC | $45,739 | 0.01% | 346,511 | Common | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $7,500 | 0.00% | 75,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.